DEVELOPMENT AGREEMENTDevelopment Agreement • May 9th, 2019 • Sophiris Bio Inc. • Pharmaceutical preparations
THIS DEVELOPMENT AGREEMENT (the “Agreement”) is made and entered into as of the 23rd day of January, 2018 (“Effective Date”), by and between Sophiris Bio Corp., a company duly organized and existing under the laws of Delaware and having its principal place of business at 1258 Prospect Street, La Jolla, California 92037 (“Customer”), and Vetter Pharma International GmbH, a company duly organized and existing under the laws of Germany, having its principal place of business at Eywiesenstraße 5, 88212 Ravensburg, Germany (“Vetter International”), Customer and Vetter International also being referred to herein individually as a “Party” and collectively as the “Parties”.
